Linkoping University
Also known as: Burn Centre, Linkoping University Hospital, Linkoping, Sweden | Crown Princess Victoria Children´s Hospital and Linköping University | Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. | Department of Health, Medicine and Caring Sciences, unit of Physiotherapy, Linköping University | Div of Pediatrics, Dept of Clinical and Molecular Medicine, Faculty of Health Sciences, Linkoping University, Sweden | Johnny Ludvigsson | Lena Nilsson | Linkoeping University | Linkoeping University, Sweden | Linköpings Universiet | Linkoping University | Linköping University, Sweden | Pain and Rehabilitation Centre, and Department of Health, Medicine and Caring Sciences, Linköping University, Sweden | Preben Kjolhede | Region Jönköping County and Linköping University | Region Östergötland and Linköping university | Section for Hematology, Linköping University Hospital | Ulla Walfridsson | Univerity Hospital Linköping, Linköping University | Universitetssjukhuset i Linköping | University Hospital in Linkoeping | University Hospital, Linkoeping | University Hospital Linkoping Sweden | University Hospital, Linköping, Sweden | University Hospital of Linkoping, Sweden | University of Linkoping | University of Linköping
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1999Last known activity
Aug 6, 2025
Timeline
1960s
- Jun 1, 1969
Linkoping University— Founded
Drugs by trial phase (105 distinct, 84 trials)
Phase 4 (16 own, 0 via acquisition)
Phase 3 (22 own, 0 via acquisition)
Phase 2 (27 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Angina, Unstable
- Anti-Glomerular Basement Membrane Disease
- Arrhythmias, Cardiac
- Arthritis, Juvenile
- Ascites
- Autoimmune Diseases
- Birth Weight
- Breast Neoplasms
- Burns
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Colonic Neoplasms
- Colorectal Neoplasms
- Communicable Diseases
- Coronary Artery Disease
- Coronary Disease
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Endocrine System Diseases
- Enterocolitis
- Enterocolitis, Necrotizing
- Failure to Thrive
- Fibrosis
- Fractures, Bone
- Glioblastoma
- Glucose Metabolism Disorders
- Heart Failure
- Humeral Fractures
- Immune System Diseases
- Infarction
- Infections
- Inflammation
- Ischemia
- Latent Autoimmune Diabetes in Adults
- Liver Cirrhosis
- Lung Neoplasms
- Lymphoma
- Metabolic Diseases
- Migraine Disorders
- Myocardial Infarction
- Myocardial Ischemia
- Neoplasms
- Osteoarthritis, Knee
- Ovarian Neoplasms
- Peripheral Nervous System Diseases
- Pharyngitis
- Postoperative Complications
- Premature Birth
- Rectal Neoplasms
- Reperfusion Injury
- Seminoma
- Spinal Stenosis
- Still's Disease, Adult-Onset
- Testicular Neoplasms
- Tonsillitis
- Tuberculosis
- Tuberculosis, Pulmonary
- Urinary Tract Infections
- Wounds and Injuries
Recent trials (50)
- NCT07199946Lead sponsorPhase 1/Phase 2Aug 6, 2025
- NCT07199946Sponsor investigatorPhase 1/Phase 2Aug 6, 2025
- NCT06648018Lead sponsorN/AOct 15, 2024
- NCT06648018OfficialN/AOct 15, 2024
- NCT06648018Sponsor investigatorN/AOct 15, 2024
- NCT06648018CollaboratorN/AOct 15, 2024
- NCT06488482CollaboratorPhase 3Sep 30, 2024
- NCT06618716Lead sponsorN/ASep 5, 2024
- NCT06618716Sponsor investigatorN/ASep 5, 2024
- NCT06419946OfficialPhase 3May 15, 2024
- NCT06349668Lead sponsorPhase 3Apr 9, 2024
- NCT06349668Sponsor investigatorPhase 3Apr 9, 2024
- NCT06349668CollaboratorPhase 3Apr 9, 2024
- NCT06044103Sponsor investigatorPhase 4Sep 20, 2023
- NCT06044103Lead sponsorPhase 4Sep 20, 2023
Details
- Founded
- Linkoping, SE Jun 1, 1969
- Last known activity
- Aug 6, 2025